Barinthus Biotherapeutics (BRNS) Prepaid Assets (2020 - 2026)

Barinthus Biotherapeutics has reported Prepaid Assets for 7 years, with the latest figure at $4.2 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets fell 32.71% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (down 32.71% YoY), and the FY2025 full-year result was $115000.0, down 66.57% from the prior year.
• Prepaid Assets for Q1 2026 stood at $4.2 million, up from $115000.0 in the prior quarter.
• The five-year high for Prepaid Assets was $9.9 million in Q2 2022, with the low at $115000.0 in Q4 2025.
• Historically, Prepaid Assets has averaged $4.4 million across 5 years, with a median of $5.5 million in 2022.
• Annual changes were most pronounced in 2022 — Prepaid Assets soared 1539.42% — and 2024, when it tumbled 96.53%.
• Barinthus Biotherapeutics' Prepaid Assets stood at $8.3 million in 2022, then rose by 19.82% to $9.9 million in 2023, then plunged by 96.53% to $344000.0 in 2024, then sank by 66.57% to $115000.0 in 2025, then soared by 3589.57% to $4.2 million in 2026.
• The last three Prepaid Assets figures came in at $4.2 million (Q1 2026), $115000.0 (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.